Sorry, but this is bull, Lee. There is many US companies involved in vaccine research. Heck my company develops and markets vaccines against diseases that we make a lot of money of on treatments. Know why? Because there is A a large base of existing patients for which a vaccine won't work and B there is always enough people that will get the disease because for whatever reason they didn't get vaccinated. Double the opportunity to make money. The problem why nothing much happens on the HIV front the following (not exhaustive):
1. There is NOT a lot of money to be made in HIV anymore. Thanks to India in particular ignoring patent laws and the UN, governments and many insurance companies reimbursing for pirated products to save a buck (despite national laws) the value of HIV as a market has decreased dramatically and it becomes very risky to develop drugs at roughly 500 million a pop (minimum investment from Pre-clinical through Phase III at a 1-10% compounded chance of clinical and regulatory success)
2. Lack of obvious targets. Most of the candidates have been exhausted and many of the more complex ideas such as virus excision from DNA often fail in the later stages because the either the delivery mechanism or the drug itself can't reach all the infected cells and at a dose that is not highly toxic.
4. High rate of virus mutation. HIV's genome is very unstable which makes it difficult to identify targets stable enough to allow for an effective treatment that covers a large population. Newer concepts try to circumvent that by targeting host DNA which doesn't mutate rather than the virus itself but many of these concepts haven't made it into later stages of clinical development yet and statistically, a majority of them will not make it to or fail in Phase III.
5. Lack of understanding of the disease. While we know A LOT about HIV, there is still a lot we don't know. For example when I left research 5 years ago, it was still mystery how HIV could kill so many CD4 T-cells when only a small fraction of them was infected at any given time even during acute onset of AIDS. More progress has been made I am sure but considering that time to market for a pharmaceutical product on average is 10-15 years, you're going to have to be patient. It's amazing how much progress has been made so far in fact.